LivaNova (LIVN) Financials

LivaNova logo
$90.74 -1.33 (-1.44%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$90.72 -0.02 (-0.03%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for LivaNova

Annual Income Statements for LivaNova

This table shows LivaNova's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 4/24/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
58 -63 -25 -189 -158 -349 -136 -86 18 63 -242
Consolidated Net Income / (Loss)
58 -63 -25 -189 -158 -349 -136 -86 18 63 -242
Net Income / (Loss) Continuing Operations
58 1.87 54 -178 -158 -347 -136 -86 18 63 -242
Total Pre-Tax Income
89 26 121 -247 -188 -348 -124 -75 -81 88 -221
Total Operating Income
89 33 96 -248 -172 -274 -0.78 -77 -68 129 199
Total Gross Profit
264 597 1,005 735 724 595 706 707 756 853 940
Total Revenue
292 965 1,005 1,096 1,084 934 1,035 1,022 1,154 1,253 1,388
Operating Revenue
292 965 1,005 1,096 1,084 934 1,035 1,022 1,154 1,253 1,388
Total Cost of Revenue
27 368 0.00 361 360 339 329 315 398 400 448
Operating Cost of Revenue
27 368 - 361 360 339 329 315 398 400 448
Total Operating Expenses
176 564 909 983 895 869 707 784 824 724 740
Selling, General & Admin Expense
124 355 380 465 564 514 472 469 503 509 549
Research & Development Expense
42 82 110 146 147 153 183 156 194 183 186
Other Operating Expenses / (Income)
- 38 - 0.00 - - 51 30 38 33 5.90
Impairment Charge
- - 0.00 0.57 185 201 0.00 129 90 0.00 0.00
Total Other Income / (Expense), net
0.16 -7.78 25 0.63 -17 -74 -124 1.61 -13 -41 -420
Interest Expense
0.02 11 7.80 9.83 15 42 110 48 59 89 52
Other Income / (Expense), net
- 1.14 40 9.60 -2.54 -32 -13 50 46 48 -368
Income Tax Expense
31 5.11 50 -70 -30 -0.96 11 11 -99 25 22
Other Gains / (Losses), net
- -19 -17 -0.64 0.00 -0.26 -0.15 -0.05 - - -0.05
Basic Earnings per Share
$2.19 ($1.29) ($0.52) ($3.91) $0.00 ($7.18) ($2.68) ($1.61) $0.33 $1.17 ($4.45)
Weighted Average Basic Shares Outstanding
26.39M 48.86M 48.16M 48.50M 48.35M 48.59M 50.63M 53.47M 53.94M 54.24M 54.55M
Diluted Earnings per Share
$2.17 ($1.28) ($0.52) ($3.91) ($3.26) ($7.18) ($2.68) ($1.61) $0.32 $1.16 ($4.45)
Weighted Average Diluted Shares Outstanding
26.63M 49.01M 48.50M 48.50M 48.35M 48.59M 50.63M 53.47M 54.21M 54.57M 54.55M
Weighted Average Basic & Diluted Shares Outstanding
- 48.70M 48.20M 48.40M 48.45M 48.66M 53.26M 53.56M 53.96M 54.35M 54.69M

Quarterly Income Statements for LivaNova

This table shows LivaNova's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-42 16 33 56 -327 27 27 31 22 109 34
Consolidated Net Income / (Loss)
-42 16 33 56 -327 27 27 31 22 109 34
Net Income / (Loss) Continuing Operations
-42 16 33 56 -327 27 27 31 22 109 34
Total Pre-Tax Income
-34 22 44 56 -316 33 34 28 27 18 47
Total Operating Income
16 40 36 37 49 54 54 43 41 49 28
Total Gross Profit
207 215 221 219 216 239 245 235 244 274 265
Total Revenue
295 319 318 322 317 353 358 361 362 391 393
Operating Revenue
295 319 318 322 317 353 358 361 362 391 393
Total Cost of Revenue
88 104 97 102 101 114 113 126 119 117 128
Operating Cost of Revenue
88 104 97 102 101 114 113 126 119 117 128
Total Operating Expenses
191 175 185 182 168 185 191 193 202 224 237
Selling, General & Admin Expense
130 125 127 136 129 138 139 139 144 158 155
Research & Development Expense
46 45 49 43 38 47 49 52 59 54 48
Other Operating Expenses / (Income)
16 4.84 9.18 3.40 0.61 -0.16 3.74 1.71 0.02 12 34
Other Special Charges / (Income)
- - 0.00 - - - - - - 0.00 0.00
Total Other Income / (Expense), net
-50 -19 8.86 19 -364 -21 -20 -15 -14 -31 18
Interest Expense
41 16 16 16 15 15 11 11 8.29 7.18 7.95
Interest & Investment Income
- - 0.04 - - - - - - -0.11 -0.08
Other Income / (Expense), net
-9.07 -3.05 25 35 -349 -5.93 -9.24 -4.09 -5.70 -24 26
Income Tax Expense
7.72 5.23 12 0.59 12 6.15 7.11 -3.28 4.34 -90 12
Basic Earnings per Share
($0.78) $0.30 $0.61 $1.04 ($6.01) $0.50 $0.49 $0.57 $0.41 $1.98 $0.62
Weighted Average Basic Shares Outstanding
54.01M 54.24M 54.35M 54.24M 54.42M 54.58M 54.63M 54.55M 54.69M 54.97M 55.09M
Diluted Earnings per Share
($0.78) $0.30 $0.60 $1.04 ($6.01) $0.50 $0.49 $0.57 $0.40 $1.93 $0.11
Weighted Average Diluted Shares Outstanding
54.01M 54.59M 54.59M 54.57M 54.42M 54.71M 55.15M 54.55M 55.94M 56.27M 57.37M
Weighted Average Basic & Diluted Shares Outstanding
54.15M 54.30M 54.30M 54.35M 54.53M 54.60M 54.61M 54.69M 54.93M 55.09M 55.09M

Annual Cash Flow Statements for LivaNova

This table details how cash moves in and out of LivaNova's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 4/24/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
21 -73 54 -46 14 192 -45 308 62 146 -88
Net Cash From Operating Activities
80 90 91 120 -91 -79 103 70 75 183 254
Net Cash From Continuing Operating Activities
80 90 91 120 -91 -79 103 70 75 183 253
Net Income / (Loss) Continuing Operations
58 -63 -25 -189 -158 -349 -136 -86 18 63 -242
Consolidated Net Income / (Loss)
58 -63 -25 -189 -158 -349 -136 -86 18 63 -242
Depreciation Expense
5.77 40 37 70 71 67 51 48 25 25 29
Amortization Expense
1.04 71 78 14 15 24 34 32 55 48 54
Non-Cash Adjustments To Reconcile Net Income
12 77 115 17 223 269 103 176 140 61 407
Changes in Operating Assets and Liabilities, net
3.07 -35 -113 210 -242 -90 50 -99 -163 -14 5.83
Net Cash From Investing Activities
-9.77 -45 -53 -121 -41 -42 37 -38 -40 -48 -73
Net Cash From Continuing Investing Activities
-9.77 -45 -53 -121 -41 -42 37 -38 -40 -48 -73
Purchase of Property, Plant & Equipment
-6.69 -38 -33 -37 -25 -35 -25 -27 -35 -47 -81
Purchase of Investments
-1.18 -8.03 -6.26 -3.77 -2.50 -3.18 -3.65 -2.95 -6.50 -1.14 -5.67
Sale of Property, Plant & Equipment
0.00 1.15 5.94 14 - - - - 1.15 0.09 7.28
Sale and/or Maturity of Investments
-1.90 7.00 3.19 - - - - - 0.00 0.00 6.52
Net Cash From Financing Activities
-48 -118 11 -42 147 311 -181 280 21 19 -286
Net Cash From Continuing Financing Activities
-48 -118 11 -42 147 311 -181 280 21 19 -286
Repayment of Debt
0.00 -79 -11 -311 -21 -567 -486 -221 -21 -318 -281
Repurchase of Common Equity
-55 -54 0.00 -50 -3.80 -24 - -3.29 0.00 -5.94 0.00
Issuance of Debt
0.00 7.23 22 344 197 934 0.00 508 50 336 0.00
Other Financing Activities, net
6.76 8.06 -0.21 -25 -26 -33 -18 -3.43 -7.48 6.68 -4.40
Effect of Exchange Rate Changes
-0.77 -0.42 - - -0.22 2.21 -2.81 -4.01 6.19 -7.75 16

Quarterly Cash Flow Statements for LivaNova

This table details how cash moves in and out of LivaNova's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
38 17 33 57 15 -145 52 -11 -96 -23 47
Net Cash From Operating Activities
9.98 43 51 79 24 63 85 82 15 67 74
Net Cash From Continuing Operating Activities
9.98 43 51 80 24 63 84 82 15 67 74
Net Income / (Loss) Continuing Operations
-42 16 33 56 -327 27 27 31 22 109 34
Consolidated Net Income / (Loss)
-42 16 33 56 -327 27 27 31 22 109 34
Depreciation Expense
6.27 10 11 11 6.42 6.87 7.72 7.56 8.30 8.75 9.10
Amortization Expense
12 7.13 8.04 7.82 14 14 13 13 12 14 14
Non-Cash Adjustments To Reconcile Net Income
35 16 -2.74 2.28 371 13 13 7.76 11 2.61 15
Changes in Operating Assets and Liabilities, net
-1.29 -6.62 2.16 3.42 -40 2.00 23 23 -38 -68 1.33
Net Cash From Investing Activities
-6.36 -13 -19 -11 -11 -8.97 -23 -30 -15 -32 -23
Net Cash From Continuing Investing Activities
-6.36 -13 -19 -11 -11 -8.97 -23 -30 -15 -32 -23
Purchase of Property, Plant & Equipment
-6.40 -12 -18 -10 -11 -15 -23 -32 -14 -32 -31
Sale and/or Maturity of Investments
- - - - - - - - - - 9.07
Other Investing Activities, net
0.04 -0.04 0.10 -0.01 0.16 -0.34 -0.18 - -0.29 -0.37 0.71
Net Cash From Financing Activities
37 -12 -3.28 -3.44 -4.42 -209 -9.37 -63 -94 -56 -2.92
Net Cash From Continuing Financing Activities
37 -12 -3.28 -3.44 -4.42 -209 -9.37 -63 -94 -56 -2.92
Repayment of Debt
-305 -3.94 -4.45 -4.38 -4.42 -205 -9.66 -62 -94 -6.02 8.81
Other Financing Activities, net
8.77 -4.13 1.40 0.95 - -3.88 0.29 -0.80 - - -12
Effect of Exchange Rate Changes
-2.95 -1.48 4.26 -7.58 5.96 10 -0.19 0.22 -2.24 -1.31 -0.79

Annual Balance Sheets for LivaNova

This table presents LivaNova's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
2,559 2,343 2,504 2,550 2,412 2,400 2,201 2,295 2,430 2,506 2,606
Total Current Assets
673 813 870 533 549 708 679 886 988 1,127 1,102
Cash & Equivalents
113 40 94 47 61 253 208 214 267 429 636
Accounts Receivable
272 213 282 256 258 184 185 183 215 193 216
Inventories, net
212 133 144 154 164 115 106 129 148 148 165
Prepaid Expenses
27 52 39 30 29 23 36 26 27 32 37
Current Deferred & Refundable Income Taxes
42 51 46 47 38 60 38 32 20 31 49
Plant, Property, & Equipment, net
245 204 192 191 181 164 150 147 154 170 243
Total Noncurrent Assets
1,641 1,326 1,442 1,825 1,681 1,528 1,372 1,261 1,287 1,209 1,262
Long-Term Investments
77 56 - - - - - - - 25 20
Goodwill
745 692 784 957 916 922 900 769 783 750 793
Intangible Assets
659 442 535 770 608 438 400 369 261 237 230
Noncurrent Deferred & Refundable Income Taxes
154 6.02 12 68 69 2.99 2.20 1.38 119 112 111
Other Noncurrent Operating Assets
5.45 131 110 30 89 165 70 123 124 85 108
Total Liabilities & Shareholders' Equity
2,559 2,343 2,504 2,550 2,412 2,400 2,201 2,295 2,430 2,506 2,606
Total Liabilities
747 636 689 1,046 1,028 1,291 906 1,087 1,152 1,186 1,406
Total Current Liabilities
359 350 406 497 513 309 697 297 335 392 808
Short-Term Debt
83 48 84 29 77 13 230 23 18 78 82
Accounts Payable
110 72 86 77 86 74 68 74 81 70 97
Accrued Expenses
63 71 79 124 120 88 89 81 107 118 503
Current Deferred & Payable Income Tax Liabilities
27 18 13 23 13 16 15 17 23 32 33
Current Employee Benefit Liabilities
77 58 66 83 70 52 79 72 95 81 93
Total Noncurrent Liabilities
388 286 283 549 516 982 209 790 817 794 598
Long-Term Debt
92 75 62 140 260 642 9.85 518 569 550 345
Noncurrent Deferred & Payable Income Tax Liabilities
235 153 123 68 32 7.09 7.73 8.52 12 11 9.59
Noncurrent Employee Benefit Liabilities
31 23 28 25 23 21 19 17 17 13 14
Other Noncurrent Operating Liabilities
30 35 69 184 176 312 173 246 220 221 230
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,811 1,707 1,815 1,504 1,384 1,109 1,295 1,208 1,278 1,320 1,200
Total Preferred & Common Equity
1,811 1,707 1,815 1,504 1,384 1,109 1,295 1,208 1,278 1,320 1,200
Total Common Equity
1,811 1,707 1,815 1,504 1,384 1,109 1,295 1,208 1,278 1,320 1,200
Common Stock
1,817 1,794 1,810 1,781 1,811 1,844 2,200 2,240 2,272 2,304 2,340
Retained Earnings
48 -15 -40 -252 -407 -762 -898 -984 -966 -903 -1,146
Treasury Stock
- -4.50 -0.13 -1.46 -1.26 -1.03 -0.65 -0.38 -0.06 -0.14 -1.17
Accumulated Other Comprehensive Income / (Loss)
-54 -68 45 -24 -19 28 -7.18 -48 -28 -80 7.33

Quarterly Balance Sheets for LivaNova

This table presents LivaNova's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
2,342 2,329 2,460 2,453 2,522 2,559 2,507 2,558 2,516 2,641 2,713
Total Current Assets
942 954 1,040 1,047 1,093 1,171 1,066 1,097 1,014 1,025 1,083
Cash & Equivalents
223 234 309 329 346 738 594 646 540 517 563
Accounts Receivable
186 190 209 201 197 202 220 212 229 231 236
Inventories, net
156 162 153 155 162 154 165 168 166 173 178
Prepaid Expenses
39 44 39 36 43 47 54 44 38 62 59
Current Deferred & Refundable Income Taxes
26 26 23 22 24 29 33 28 41 43 46
Plant, Property, & Equipment, net
150 149 152 158 169 178 195 219 255 273 293
Total Noncurrent Assets
1,250 1,226 1,267 1,248 1,260 1,210 1,245 1,242 1,247 1,342 1,337
Long-Term Investments
- - - - - - - - 18 15 17
Goodwill
779 767 772 766 782 762 793 791 786 779 779
Intangible Assets
357 348 254 248 249 237 239 235 225 217 211
Noncurrent Deferred & Refundable Income Taxes
2.11 1.51 114 113 110 109 110 107 110 199 194
Other Noncurrent Operating Assets
111 110 128 121 119 102 103 109 108 132 136
Total Liabilities & Shareholders' Equity
2,342 2,329 2,460 2,453 2,522 2,559 2,507 2,558 2,516 2,641 2,713
Total Liabilities
1,101 1,104 1,238 1,211 1,212 1,524 1,384 1,400 1,305 1,316 1,341
Total Current Liabilities
288 295 328 303 324 742 827 828 762 707 740
Short-Term Debt
19 19 20 20 22 80 130 134 62 3.58 3.90
Accounts Payable
78 63 76 81 78 88 87 88 99 103 107
Accrued Expenses
82 90 94 98 105 469 496 487 492 489 513
Current Deferred & Payable Income Tax Liabilities
20 22 30 23 27 40 34 21 42 22 29
Current Employee Benefit Liabilities
67 75 91 65 77 53 68 80 58 69 88
Total Noncurrent Liabilities
813 809 910 908 888 783 557 573 543 609 601
Long-Term Debt
568 568 605 605 604 549 348 349 285 290 295
Noncurrent Deferred & Payable Income Tax Liabilities
8.92 9.93 11 11 12 11 11 10 6.81 9.31 7.74
Noncurrent Employee Benefit Liabilities
17 16 17 16 15 13 14 14 13 14 14
Other Noncurrent Operating Liabilities
219 215 278 275 257 210 183 200 237 295 284
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,241 1,225 1,222 1,243 1,310 1,034 1,123 1,157 1,211 1,325 1,372
Total Preferred & Common Equity
1,241 1,225 1,222 1,243 1,310 1,034 1,123 1,157 1,211 1,325 1,372
Total Common Equity
1,241 1,225 1,222 1,243 1,310 1,034 1,123 1,157 1,211 1,325 1,372
Common Stock
2,252 2,263 2,276 2,288 2,296 2,309 2,319 2,330 2,339 2,355 2,369
Retained Earnings
-976 -983 -1,008 -992 -959 -1,231 -1,203 -1,177 -1,123 -1,015 -981
Treasury Stock
-0.10 -0.06 -0.48 -0.20 -0.16 -1.43 -1.16 -1.20 -1.17 -0.73 -0.69
Accumulated Other Comprehensive Income / (Loss)
-36 -55 -45 -53 -27 -43 8.11 5.51 -3.40 -14 -15

Annual Metrics And Ratios for LivaNova

This table displays calculated financial ratios and metrics derived from LivaNova's official financial filings.

Metric 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 4/24/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 0.00% 4.16% 9.08% -1.10% -13.83% 10.82% -1.31% 12.89% 8.66% 10.74%
EBITDA Growth
11.85% 0.00% 71.97% -161.75% 42.62% -141.57% 132.86% -25.97% 10.14% 333.82% -134.52%
EBIT Growth
11.21% 0.00% 293.77% -275.11% 27.00% -75.64% 95.39% -90.95% 16.80% 890.52% -195.47%
NOPAT Growth
4.46% 0.00% 111.68% -406.27% 30.85% -59.66% 99.71% -9,689.80% 10.75% 292.77% 51.00%
Net Income Growth
0.00% 0.00% 60.04% -654.91% 16.77% -121.28% 61.06% 36.50% 120.34% 260.39% -483.45%
EPS Growth
0.00% 0.00% 59.38% -651.92% 16.62% -120.25% 62.67% 39.93% 119.88% 262.50% -483.62%
Operating Cash Flow Growth
0.00% 0.00% 1.32% 31.91% -175.64% 12.86% 229.11% -31.81% 7.14% 144.33% 38.95%
Free Cash Flow Firm Growth
206.97% 0.00% 0.00% 26.79% -50.36% 98.30% 5,578.72% -73.05% -358.98% 253.21% 104.90%
Invested Capital Growth
-5.74% 0.00% 13.23% -4.14% 2.18% -11.39% -9.86% -6.99% 4.29% -4.83% -19.05%
Revenue Q/Q Growth
0.00% 0.00% 26.12% 1.33% 0.12% -1.74% -0.09% 0.47% 3.15% 0.94% 2.90%
EBITDA Q/Q Growth
0.00% 0.00% 13.34% -185.45% 58.62% -169.21% 132.92% 39.74% -62.97% 147.44% -58.33%
EBIT Q/Q Growth
0.00% 0.00% 30.74% -346.94% 42.54% -79.84% 95.34% 36.88% -129.42% 581.81% -24.99%
NOPAT Q/Q Growth
0.00% 0.00% -44.89% -31,711.46% 43.07% -62.27% 99.72% -16.37% -1,034.95% 3,168.48% 2.87%
Net Income Q/Q Growth
0.00% 0.00% -144.17% -109.22% 29.15% -65.42% 67.22% 7.30% 511.79% 167.01% -11.49%
EPS Q/Q Growth
0.00% 0.00% -144.07% -109.09% 28.98% -65.06% 68.32% 5.85% 433.33% 176.19% -11.81%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -20.21% 2.74% -24.65% 30.05% -3.31% -17.45% 88.90% 15.64% 1.47%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% -2,292.93% -215.76% -15.57% 97.98% -31.43% -72.66% -7.08% 1,082.92% -10.41%
Invested Capital Q/Q Growth
0.00% -18.21% -12.03% -11.60% -5.75% -17.07% -3.14% 4.48% 0.51% -3.57% -2.40%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
90.63% 61.88% 100.00% 67.04% 66.76% 63.66% 68.19% 69.21% 66.86% 69.48% 67.71%
EBITDA Margin
32.74% 15.12% 24.96% -14.13% -8.20% -22.99% 6.82% 5.11% 4.99% 19.91% -6.21%
Operating Margin
30.41% 3.47% 9.60% -22.63% -15.82% -29.32% -0.08% -7.51% -5.94% 10.30% 14.36%
EBIT Margin
30.41% 3.58% 13.55% -21.75% -16.06% -32.73% -1.36% -2.63% -1.94% 14.11% -12.16%
Profit (Net Income) Margin
19.84% -6.51% -2.50% -17.28% -14.54% -37.34% -13.12% -8.44% 1.52% 5.04% -17.47%
Tax Burden Percent
64.78% -244.64% -20.71% 76.54% 83.68% 100.23% 109.12% 114.78% -21.60% 71.60% 109.82%
Interest Burden Percent
100.72% 74.21% 88.95% 103.76% 108.21% 113.82% 883.85% 279.42% 363.05% 49.93% 130.76%
Effective Tax Rate
35.22% 19.92% 41.24% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 28.38% 0.00%
Return on Invested Capital (ROIC)
51.49% 1.79% 3.55% -10.46% -7.31% -12.25% -0.04% -4.20% -3.81% 7.36% 12.86%
ROIC Less NNEP Spread (ROIC-NNEP)
51.23% 44.48% 53.11% -3,545.50% -26.19% -61.45% -68.79% -117.48% 374.07% 74.37% 231.07%
Return on Net Nonoperating Assets (RNNOA)
-31.18% -5.47% -4.98% -0.95% -3.61% -15.74% -11.26% -2.70% 5.22% -2.49% -32.11%
Return on Equity (ROE)
20.31% -3.68% -1.42% -11.41% -10.92% -27.98% -11.30% -6.89% 1.41% 4.87% -19.24%
Cash Return on Invested Capital (CROIC)
57.40% 0.00% -8.85% -6.23% -9.47% -0.17% 10.33% 3.04% -8.00% 12.31% 33.91%
Operating Return on Assets (OROA)
28.06% 1.41% 5.62% -9.44% -7.02% -12.71% -0.61% -1.20% -0.95% 7.17% -6.61%
Return on Assets (ROA)
18.31% -2.56% -1.04% -7.50% -6.35% -14.50% -5.90% -3.84% 0.74% 2.56% -9.49%
Return on Common Equity (ROCE)
20.31% -3.68% -1.42% -11.41% -10.92% -27.98% -11.30% -6.89% 1.41% 4.87% -19.24%
Return on Equity Simple (ROE_SIMPLE)
20.92% -3.68% -1.38% -12.60% -11.39% -31.45% -10.49% -7.14% 1.37% 4.79% 0.00%
Net Operating Profit after Tax (NOPAT)
57 27 57 -174 -120 -192 -0.55 -54 -48 92 140
NOPAT Margin
19.70% 2.78% 5.64% -15.84% -11.08% -20.52% -0.05% -5.26% -4.16% 7.37% 10.06%
Net Nonoperating Expense Percent (NNEP)
0.27% -42.69% -49.56% 3,535.04% 18.88% 49.20% 68.76% 113.28% -377.87% -67.01% -218.21%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - -3.07% -2.57% 4.75% 8.58%
Cost of Revenue to Revenue
9.37% 38.12% 0.00% 32.96% 33.24% 36.34% 31.81% 30.79% 33.14% 30.52% 32.29%
SG&A Expenses to Revenue
42.40% 36.81% 37.82% 42.41% 51.98% 55.05% 45.58% 45.92% 44.92% 41.99% 39.54%
R&D to Revenue
14.49% 8.51% 10.90% 13.31% 13.54% 16.37% 17.71% 15.25% 16.80% 14.56% 13.38%
Operating Expenses to Revenue
60.23% 58.41% 90.40% 89.67% 82.58% 92.98% 68.26% 76.73% 72.80% 59.18% 53.35%
Earnings before Interest and Taxes (EBIT)
89 35 136 -238 -174 -306 -14 -27 -22 177 -169
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
95 146 251 -155 -89 -215 71 52 58 250 -86
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 1.29 2.12 2.96 2.64 2.90 3.59 2.46 2.18 1.90 2.80
Price to Tangible Book Value (P/TBV)
0.00 3.82 7.77 0.00 0.00 0.00 0.00 42.30 11.94 7.55 18.96
Price to Revenue (P/Rev)
0.00 2.27 3.83 4.06 3.37 3.44 4.49 2.91 2.42 2.01 2.42
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 158.86 39.77 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.63% 2.51% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 1.48 2.30 2.82 2.37 2.46 3.53 2.43 2.17 1.98 3.22
Enterprise Value to Revenue (EV/Rev)
0.00 2.30 3.89 4.17 3.62 3.88 4.53 2.93 2.42 1.93 2.26
Enterprise Value to EBITDA (EV/EBITDA)
0.00 15.22 15.57 0.00 0.00 0.00 66.40 57.40 48.60 9.69 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 64.20 28.68 0.00 0.00 0.00 0.00 0.00 0.00 13.68 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 82.89 68.88 0.00 0.00 0.00 0.00 0.00 0.00 26.17 22.43
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 24.63 42.76 37.96 0.00 0.00 45.69 42.88 37.32 13.21 12.31
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 32.42 77.00 0.00 15.65 8.51
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.07 0.08 0.11 0.24 0.59 0.19 0.45 0.46 0.48 0.36
Long-Term Debt to Equity
0.00 0.04 0.03 0.09 0.19 0.58 0.01 0.43 0.45 0.42 0.29
Financial Leverage
-0.61 -0.12 -0.09 0.00 0.14 0.26 0.16 0.02 0.01 -0.03 -0.14
Leverage Ratio
1.14 1.39 1.38 1.52 1.72 1.93 1.91 1.80 1.90 1.90 2.03
Compound Leverage Factor
1.15 1.03 1.22 1.58 1.86 2.20 16.92 5.02 6.90 0.95 2.65
Debt to Total Capital
0.00% 6.71% 7.44% 10.07% 19.62% 37.15% 15.61% 30.96% 31.47% 32.22% 26.23%
Short-Term Debt to Total Capital
0.00% 2.60% 4.28% 1.72% 4.50% 0.76% 14.97% 1.34% 0.97% 4.00% 5.01%
Long-Term Debt to Total Capital
0.00% 4.11% 3.16% 8.35% 15.12% 36.39% 0.64% 29.62% 30.50% 28.22% 21.22%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 93.29% 92.56% 89.93% 80.38% 62.85% 84.39% 69.04% 68.53% 67.78% 73.77%
Debt to EBITDA
0.00 0.84 0.58 -1.09 -3.80 -3.05 3.39 10.37 10.20 2.51 -4.95
Net Debt to EBITDA
0.00 0.18 0.21 -0.78 -3.11 -1.88 0.45 0.50 0.15 -0.38 2.66
Long-Term Debt to EBITDA
0.00 0.52 0.25 -0.90 -2.93 -2.99 0.14 9.92 9.88 2.20 -4.01
Debt to NOPAT
0.00 4.59 2.57 -0.97 -2.81 -3.42 -436.45 -10.08 -12.24 6.79 3.06
Net Debt to NOPAT
0.00 1.00 0.92 -0.70 -2.30 -2.10 -57.45 -0.48 -0.18 -1.04 -1.64
Long-Term Debt to NOPAT
0.00 2.81 1.09 -0.80 -2.17 -3.35 -17.95 -9.64 -11.86 5.95 2.47
Altman Z-Score
0.00 2.76 4.14 2.55 2.12 1.22 2.95 1.75 1.66 1.85 1.27
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
7.65 2.32 2.14 1.07 1.07 2.29 0.97 2.98 2.95 2.87 1.36
Quick Ratio
6.42 0.72 0.93 0.61 0.62 1.41 0.56 1.34 1.44 1.59 1.05
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
64 0.00 -141 -103 -156 -2.64 144 39 -101 155 368
Operating Cash Flow to CapEx
1,191.51% 242.23% 338.32% 524.60% -369.13% -226.76% 402.48% 263.68% 214.16% 388.56% 344.78%
Free Cash Flow to Firm to Interest Expense
3,048.57 0.00 -18.12 -10.53 -10.31 -0.06 1.31 0.81 -1.71 1.74 7.09
Operating Cash Flow to Interest Expense
3,794.10 8.49 11.71 12.26 -6.04 -1.88 0.93 1.45 1.27 2.07 4.90
Operating Cash Flow Less CapEx to Interest Expense
3,475.67 4.99 8.25 9.93 -7.68 -2.71 0.70 0.90 0.68 1.54 3.48
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.92 0.39 0.41 0.43 0.44 0.39 0.45 0.45 0.49 0.51 0.54
Accounts Receivable Turnover
5.77 3.97 4.06 4.07 4.22 4.23 5.60 5.55 5.79 6.14 6.79
Inventory Turnover
1.14 2.13 0.00 2.42 2.27 2.43 2.98 2.67 2.76 2.59 2.87
Fixed Asset Turnover
7.24 4.30 5.08 5.71 5.82 5.41 6.60 6.88 7.66 7.73 6.72
Accounts Payable Turnover
3.77 4.05 0.00 4.44 4.43 4.26 4.65 4.42 4.93 5.08 5.37
Days Sales Outstanding (DSO)
63.31 91.85 89.96 89.61 86.51 86.37 65.17 65.81 63.00 59.44 53.79
Days Inventory Outstanding (DIO)
320.26 171.40 0.00 150.52 160.89 150.22 122.52 136.46 132.36 140.94 127.16
Days Payable Outstanding (DPO)
96.91 90.06 0.00 82.15 82.36 85.78 78.50 82.56 74.07 71.83 67.95
Cash Conversion Cycle (CCC)
286.66 173.19 89.96 157.98 165.03 150.81 109.19 119.71 121.29 128.55 112.99
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
108 1,497 1,695 1,625 1,660 1,471 1,326 1,234 1,286 1,224 971
Invested Capital Turnover
2.61 0.64 0.63 0.66 0.66 0.60 0.74 0.80 0.92 1.00 1.28
Increase / (Decrease) in Invested Capital
-6.59 0.00 198 -70 35 -189 -145 -93 53 -62 -228
Enterprise Value (EV)
0.00 2,220 3,905 4,574 3,927 3,620 4,685 2,999 2,796 2,419 3,131
Market Capitalization
0.00 2,193 3,853 4,453 3,651 3,218 4,654 2,973 2,787 2,515 3,360
Book Value per Share
$10.48 $35.00 $37.65 $30.89 $28.59 $22.83 $24.32 $22.56 $23.72 $24.31 $21.98
Tangible Book Value per Share
$10.09 $11.76 $10.28 ($4.59) ($2.88) ($5.16) ($0.09) $1.31 $4.33 $6.13 $3.24
Total Capital
277 1,830 1,961 1,672 1,721 1,765 1,534 1,749 1,864 1,948 1,627
Total Debt
0.00 123 146 168 338 656 240 542 587 628 427
Total Long-Term Debt
0.00 75 62 140 260 642 9.85 518 569 550 345
Net Debt
-168 27 52 121 277 403 32 26 8.78 -96 -229
Capital Expenditures (CapEx)
6.69 37 27 23 25 35 25 27 35 47 74
Debt-free, Cash-free Net Working Capital (DFCFNWC)
58 471 454 18 53 160 3.89 97 93 90 -261
Debt-free Net Working Capital (DFNWC)
209 510 548 65 114 412 212 612 671 813 375
Net Working Capital (NWC)
209 463 464 37 37 399 -18 589 653 735 294
Net Nonoperating Expense (NNE)
-0.42 90 82 16 38 157 135 33 -65 29 382
Net Nonoperating Obligations (NNO)
-168 -210 -120 121 277 362 32 26 8.78 -96 -229
Total Depreciation and Amortization (D&A)
6.81 111 115 84 85 91 85 79 80 73 83
Debt-free, Cash-free Net Working Capital to Revenue
19.92% 48.78% 45.20% 1.65% 4.90% 17.07% 0.38% 9.45% 8.10% 7.14% -18.77%
Debt-free Net Working Capital to Revenue
71.78% 52.90% 54.51% 5.96% 10.54% 44.14% 20.46% 59.91% 58.19% 64.87% 27.02%
Net Working Capital to Revenue
71.78% 47.97% 46.15% 3.33% 3.40% 42.71% -1.72% 57.62% 56.62% 58.64% 21.15%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($0.52) ($3.91) ($3.21) ($7.10) ($2.68) ($1.61) $0.33 $1.17 ($4.45)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 48.16M 48.50M 48.35M 48.59M 50.63M 53.47M 53.94M 54.24M 54.55M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($0.52) ($3.91) ($3.21) ($7.10) ($2.68) ($1.61) $0.32 $1.16 ($4.45)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 48.50M 48.50M 48.35M 48.59M 50.63M 53.47M 54.21M 54.57M 54.55M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 48.30M 48.28M 48.45M 48.66M 53.26M 53.56M 53.96M 54.35M 54.69M
Normalized Net Operating Profit after Tax (NOPAT)
63 73 76 61 9.37 -51 -0.55 37 15 92 140
Normalized NOPAT Margin
21.63% 7.57% 7.55% 5.55% 0.86% -5.43% -0.05% 3.61% 1.30% 7.37% 10.06%
Pre Tax Income Margin
30.63% 2.66% 12.05% -22.57% -17.38% -37.25% -12.02% -7.35% -7.04% 7.05% -15.91%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
4,221.52 3.26 17.47 -24.27 -11.54 -7.24 -0.13 -0.56 -0.38 2.00 -3.25
NOPAT to Interest Expense
2,734.86 2.52 7.27 -17.67 -7.96 -4.54 -0.01 -1.11 -0.81 1.04 2.69
EBIT Less CapEx to Interest Expense
3,903.10 -0.25 14.00 -26.61 -13.17 -8.07 -0.36 -1.11 -0.97 1.47 -4.67
NOPAT Less CapEx to Interest Expense
2,416.43 -0.98 3.81 -20.01 -9.59 -5.37 -0.24 -1.66 -1.41 0.51 1.27
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
95.10% -86.78% 0.00% -26.40% -2.41% -6.80% 0.00% -3.82% 0.00% 9.39% 0.00%

Quarterly Metrics And Ratios for LivaNova

This table displays calculated financial ratios and metrics derived from LivaNova's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - - 54,689,876.00 54,933,538.00 55,093,507.00
DEI Adjusted Shares Outstanding
- - - - - - - - 54,689,876.00 54,933,538.00 55,093,507.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 0.41 1.98 0.62
Growth Metrics
- - - - - - - - - - -
Revenue Growth
11.96% 8.40% 11.19% 3.77% 7.44% 10.66% 12.46% 12.15% 14.33% 10.80% 9.89%
EBITDA Growth
-41.60% 38.35% 140.64% 256.46% -1,210.55% 26.14% -16.59% -34.98% 120.05% -29.30% 17.92%
EBIT Growth
-69.08% 84.78% 363.71% 191.83% -4,286.20% 29.98% -25.77% -46.72% 111.91% -46.83% 22.23%
NOPAT Growth
741.22% 681.92% 745.39% 159.48% 199.26% 45.13% 61.79% 30.03% 2.62% 558.74% -51.05%
Net Income Growth
-669.10% 1,314.11% 550.30% 242.07% -680.40% 66.30% -18.72% -44.70% 106.81% 299.72% 28.04%
EPS Growth
-657.14% 1,400.00% 528.57% 246.67% -670.51% 66.67% -18.33% -45.19% 106.66% 286.00% -77.55%
Operating Cash Flow Growth
-51.92% 341.71% 181.18% 45.87% 140.12% 45.12% 66.80% 4.69% -36.51% 5.83% -13.40%
Free Cash Flow Firm Growth
-54.47% 71.76% 138.06% 186.22% 1,115.68% 203.74% 767.74% 122.98% -112.05% -21.61% -123.71%
Invested Capital Growth
-1.33% -4.54% -0.80% -4.83% -24.84% -18.35% -21.66% -19.05% 8.20% 7.82% 9.67%
Revenue Q/Q Growth
-4.91% 8.02% -0.14% 1.17% -1.55% 11.26% 1.48% 0.89% 0.37% 7.82% 0.66%
EBITDA Q/Q Growth
143.48% 116.98% 44.30% 14.94% -408.60% 124.65% -4.58% -10.41% -4.84% -13.09% 59.16%
EBIT Q/Q Growth
109.12% 417.37% 62.49% 19.77% -515.74% 116.06% -7.21% -14.03% -7.05% -28.29% 113.32%
NOPAT Q/Q Growth
118.46% 167.68% -13.34% 38.87% -7.11% 29.82% -3.39% 11.61% -26.69% 733.38% -92.82%
Net Income Q/Q Growth
-356.70% 138.94% 101.76% 69.61% -685.64% 108.30% -1.39% 15.39% -27.87% 386.99% -68.41%
EPS Q/Q Growth
-360.00% 138.46% 100.00% 73.33% -677.88% 108.32% -2.00% 16.33% -29.82% 382.50% -94.30%
Operating Cash Flow Q/Q Growth
-81.50% 334.39% 17.62% 54.35% -69.55% 162.54% 35.18% -3.13% -81.53% 337.62% 10.63%
Free Cash Flow Firm Q/Q Growth
124.40% 218.94% -58.91% 169.60% 244.11% -20.31% 17.38% -13.12% -114.83% 618.47% -135.50%
Invested Capital Q/Q Growth
-4.36% 0.35% 2.84% -3.57% -24.48% 9.02% -1.33% -2.40% 3.06% 8.64% 0.37%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
70.32% 68.70% 70.81% 68.16% 69.68% 67.79% 68.44% 65.18% 67.29% 70.07% 67.42%
EBITDA Margin
8.55% 17.17% 24.82% 28.19% -88.37% 19.58% 18.41% 16.35% 15.50% 12.49% 19.75%
Operating Margin
5.51% 12.61% 11.20% 11.50% 15.34% 15.37% 15.10% 11.80% 11.45% 12.67% 7.23%
EBIT Margin
2.43% 11.65% 18.96% 22.45% -94.79% 13.69% 12.52% 10.66% 9.88% 6.57% 13.92%
Profit (Net Income) Margin
-14.22% 5.13% 10.36% 17.37% -103.30% 7.70% 7.49% 8.56% 6.15% 27.80% 8.72%
Tax Burden Percent
122.64% 75.65% 74.15% 98.96% 103.70% 81.52% 78.98% 111.84% 81.11% 587.53% 73.32%
Interest Burden Percent
-476.66% 58.16% 73.68% 78.18% 105.09% 69.06% 75.74% 71.79% 76.83% 72.03% 85.47%
Effective Tax Rate
0.00% 24.21% 25.93% 1.04% 0.00% 18.46% 20.98% -11.88% 15.79% -488.14% 26.50%
Return on Invested Capital (ROIC)
3.69% 9.15% 8.08% 11.37% 12.71% 14.63% 14.21% 16.88% 14.36% 104.67% 7.68%
ROIC Less NNEP Spread (ROIC-NNEP)
-372.91% -53.95% 101.10% -32.83% 729.19% 42.38% 29.88% 26.44% 22.24% 208.01% 1.64%
Return on Net Nonoperating Assets (RNNOA)
-4.31% -0.97% 0.56% 1.10% -32.61% -2.20% -2.46% -3.67% -3.17% -30.01% -0.29%
Return on Equity (ROE)
-0.62% 8.17% 8.64% 12.47% -19.89% 12.44% 11.76% 13.21% 11.18% 74.67% 7.39%
Cash Return on Invested Capital (CROIC)
-1.48% 3.14% 1.02% 12.31% 38.85% 31.15% 36.28% 33.91% 9.75% 24.04% 16.21%
Operating Return on Assets (OROA)
1.21% 5.88% 9.71% 11.40% -48.18% 7.23% 6.65% 5.79% 5.58% 3.76% 7.96%
Return on Assets (ROA)
-7.09% 2.59% 5.30% 8.82% -52.51% 4.07% 3.98% 4.65% 3.48% 15.89% 4.99%
Return on Common Equity (ROCE)
-0.62% 8.17% 8.64% 12.47% -19.89% 12.44% 11.76% 13.21% 11.18% 74.67% 7.39%
Return on Equity Simple (ROE_SIMPLE)
-2.60% -1.34% 1.81% 0.00% -21.48% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
11 30 26 37 34 44 43 48 35 291 21
NOPAT Margin
3.86% 9.56% 8.29% 11.38% 10.74% 12.53% 11.93% 13.20% 9.64% 74.51% 5.31%
Net Nonoperating Expense Percent (NNEP)
376.60% 63.10% -93.02% 44.19% -716.47% -27.74% -15.67% -9.55% -7.88% -103.34% 6.04%
Return On Investment Capital (ROIC_SIMPLE)
- - - 1.88% 2.05% 2.76% 2.60% 2.93% 2.24% 17.98% 1.25%
Cost of Revenue to Revenue
29.68% 31.30% 29.19% 31.84% 30.32% 32.21% 31.56% 34.82% 32.71% 29.93% 32.58%
SG&A Expenses to Revenue
44.03% 40.53% 41.39% 42.14% 42.19% 39.08% 38.72% 38.47% 39.63% 40.48% 39.41%
R&D to Revenue
15.48% 14.04% 15.34% 13.46% 11.95% 13.38% 13.58% 14.44% 16.20% 13.74% 12.13%
Operating Expenses to Revenue
64.81% 56.09% 59.61% 56.66% 54.33% 52.42% 53.34% 53.38% 55.84% 57.40% 60.19%
Earnings before Interest and Taxes (EBIT)
7.18 37 60 72 -300 48 45 38 36 26 55
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
25 55 79 91 -280 69 66 59 56 49 78
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.47 2.39 2.18 1.90 2.06 2.19 2.47 2.80 2.87 3.41 3.07
Price to Tangible Book Value (P/TBV)
15.42 13.02 10.19 7.55 59.65 27.18 21.72 18.96 17.28 13.72 11.02
Price to Revenue (P/Rev)
2.55 2.45 2.30 2.01 1.67 1.87 2.12 2.42 2.43 3.07 2.80
Price to Earnings (P/E)
0.00 0.00 120.46 39.77 0.00 0.00 0.00 0.00 32.44 23.96 21.50
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.83% 2.51% 0.00% 0.00% 0.00% 0.00% 3.08% 4.17% 4.65%
Enterprise Value to Invested Capital (EV/IC)
2.46 2.40 2.22 1.98 2.19 2.32 2.71 3.22 3.26 3.94 3.61
Enterprise Value to Revenue (EV/Rev)
2.55 2.45 2.27 1.93 1.59 1.79 2.00 2.26 2.28 2.91 2.61
Enterprise Value to EBITDA (EV/EBITDA)
76.49 54.09 27.88 9.69 0.00 0.00 0.00 0.00 13.06 18.62 16.28
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 108.42 13.68 0.00 0.00 0.00 0.00 19.52 29.57 25.44
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 994.51 26.17 17.92 19.05 19.88 22.43 19.24 12.94 14.83
Enterprise Value to Operating Cash Flow (EV/OCF)
47.20 23.60 17.77 13.21 10.28 10.80 10.76 12.31 13.30 17.17 16.54
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 74.59 215.32 15.65 4.84 6.70 6.57 8.51 34.78 16.99 23.28
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.51 0.50 0.48 0.48 0.61 0.43 0.42 0.36 0.29 0.22 0.22
Long-Term Debt to Equity
0.50 0.49 0.46 0.42 0.53 0.31 0.30 0.29 0.24 0.22 0.22
Financial Leverage
0.01 0.02 0.01 -0.03 -0.04 -0.05 -0.08 -0.14 -0.14 -0.14 -0.18
Leverage Ratio
1.94 1.93 1.91 1.90 2.22 2.10 2.06 2.03 2.26 2.10 2.08
Compound Leverage Factor
-9.25 1.12 1.41 1.49 2.34 1.45 1.56 1.46 1.74 1.51 1.78
Debt to Total Capital
33.83% 33.47% 32.34% 32.22% 37.81% 29.90% 29.47% 26.23% 22.29% 18.13% 17.90%
Short-Term Debt to Total Capital
1.07% 1.06% 1.13% 4.00% 4.78% 8.14% 8.20% 5.01% 3.99% 0.22% 0.23%
Long-Term Debt to Total Capital
32.76% 32.42% 31.21% 28.22% 33.02% 21.76% 21.27% 21.22% 18.29% 17.91% 17.66%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
66.17% 66.53% 67.66% 67.78% 62.19% 70.10% 70.53% 73.77% 77.71% 81.87% 82.10%
Debt to EBITDA
15.78 11.42 6.21 2.51 -11.30 -11.59 -8.89 -4.95 1.39 1.28 1.24
Net Debt to EBITDA
0.22 -0.15 -0.40 -0.38 1.97 2.78 2.99 2.66 -0.84 -1.04 -1.16
Long-Term Debt to EBITDA
15.28 11.06 5.99 2.20 -9.87 -8.43 -6.41 -4.01 1.14 1.26 1.22
Debt to NOPAT
-17.87 -32.93 221.44 6.79 5.56 3.90 3.56 3.06 2.05 0.89 1.13
Net Debt to NOPAT
-0.25 0.42 -14.26 -1.04 -0.97 -0.93 -1.20 -1.64 -1.24 -0.72 -1.06
Long-Term Debt to NOPAT
-17.31 -31.89 213.68 5.95 4.86 2.84 2.57 2.47 1.68 0.88 1.11
Altman Z-Score
1.73 1.81 1.82 1.71 0.48 1.09 1.29 1.53 1.71 2.26 2.15
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.17 3.45 3.37 2.87 1.58 1.29 1.33 1.36 1.33 1.45 1.46
Quick Ratio
1.58 1.75 1.68 1.59 1.27 0.98 1.04 1.05 1.01 1.06 1.08
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
28 89 37 99 340 271 318 276 -41 212 -75
Operating Cash Flow to CapEx
156.00% 356.66% 281.01% 756.36% 222.11% 415.40% 371.75% 255.63% 106.48% 211.06% 239.37%
Free Cash Flow to Firm to Interest Expense
0.68 5.74 2.31 6.26 22.22 18.13 29.25 25.43 -4.94 29.57 -9.47
Operating Cash Flow to Interest Expense
0.24 2.79 3.21 4.99 1.57 4.21 7.83 7.59 1.84 9.28 9.26
Operating Cash Flow Less CapEx to Interest Expense
0.09 2.01 2.07 4.33 0.86 3.20 5.72 4.62 0.11 4.88 5.39
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.50 0.50 0.51 0.51 0.51 0.53 0.53 0.54 0.56 0.57 0.57
Accounts Receivable Turnover
6.11 6.26 6.42 6.14 6.20 6.22 6.60 6.79 6.65 6.52 6.73
Inventory Turnover
2.57 2.52 2.47 2.59 2.55 2.51 2.53 2.87 2.92 2.78 2.81
Fixed Asset Turnover
7.87 7.87 7.79 7.73 7.73 7.41 6.96 6.72 6.62 6.28 5.89
Accounts Payable Turnover
5.02 4.91 5.69 5.08 4.78 4.77 5.02 5.37 4.99 4.93 4.97
Days Sales Outstanding (DSO)
59.71 58.35 56.88 59.44 58.89 58.69 55.30 53.79 54.92 56.00 54.25
Days Inventory Outstanding (DIO)
141.80 145.05 147.72 140.94 143.34 145.68 144.42 127.16 125.11 131.38 130.07
Days Payable Outstanding (DPO)
72.75 74.37 64.17 71.83 76.33 76.58 72.71 67.95 73.14 73.99 73.45
Cash Conversion Cycle (CCC)
128.76 129.03 140.42 128.55 125.89 127.79 127.00 112.99 106.89 113.39 110.86
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,230 1,235 1,270 1,224 925 1,008 995 971 1,001 1,087 1,091
Invested Capital Turnover
0.96 0.96 0.97 1.00 1.18 1.17 1.19 1.28 1.49 1.40 1.45
Increase / (Decrease) in Invested Capital
-17 -59 -10 -62 -306 -227 -275 -228 76 79 96
Enterprise Value (EV)
3,027 2,961 2,812 2,419 2,025 2,340 2,697 3,131 3,265 4,279 3,933
Market Capitalization
3,018 2,969 2,853 2,515 2,135 2,455 2,860 3,360 3,476 4,517 4,215
Book Value per Share
$22.64 $22.95 $24.13 $24.31 $19.03 $20.59 $21.19 $21.98 $22.15 $24.13 $24.90
Tangible Book Value per Share
$3.63 $4.21 $5.16 $6.13 $0.66 $1.66 $2.41 $3.24 $3.68 $5.99 $6.94
Total Capital
1,846 1,868 1,936 1,948 1,663 1,602 1,641 1,627 1,559 1,619 1,671
Total Debt
624 625 626 628 629 479 484 427 347 293 299
Total Long-Term Debt
605 605 604 550 549 348 349 345 285 290 295
Net Debt
8.77 -7.95 -40 -96 -110 -115 -163 -229 -211 -238 -281
Capital Expenditures (CapEx)
6.40 12 18 10 11 15 23 32 14 32 31
Debt-free, Cash-free Net Working Capital (DFCFNWC)
116 130 124 90 -229 -224 -242 -261 -226 -195 -217
Debt-free Net Working Capital (DFNWC)
732 763 791 813 509 369 404 375 314 322 347
Net Working Capital (NWC)
712 744 769 735 430 239 270 294 252 318 343
Net Nonoperating Expense (NNE)
53 14 -6.57 -19 361 17 16 17 13 182 -13
Net Nonoperating Obligations (NNO)
8.77 -7.95 -40 -96 -110 -115 -163 -229 -211 -238 -281
Total Depreciation and Amortization (D&A)
18 18 19 18 20 21 21 21 20 23 23
Debt-free, Cash-free Net Working Capital to Revenue
9.81% 10.77% 9.99% 7.14% -17.98% -17.12% -17.94% -18.77% -15.75% -13.25% -14.39%
Debt-free Net Working Capital to Revenue
61.77% 63.11% 63.67% 64.87% 39.92% 28.22% 29.95% 27.02% 21.90% 21.86% 23.00%
Net Working Capital to Revenue
60.10% 61.48% 61.91% 58.64% 33.68% 18.26% 19.98% 21.15% 17.56% 21.61% 22.74%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.78) $0.30 $0.61 $1.04 ($6.01) $0.50 $0.49 $0.57 $0.41 $1.98 $0.62
Adjusted Weighted Average Basic Shares Outstanding
54.01M 54.24M 54.35M 54.24M 54.42M 54.58M 54.63M 54.55M 54.69M 54.97M 55.09M
Adjusted Diluted Earnings per Share
($0.78) $0.30 $0.60 $1.04 ($6.01) $0.50 $0.49 $0.57 $0.40 $1.93 $0.11
Adjusted Weighted Average Diluted Shares Outstanding
54.01M 54.59M 54.59M 54.57M 54.42M 54.71M 55.15M 54.55M 55.94M 56.27M 57.37M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
54.15M 54.30M 54.30M 54.35M 54.53M 54.60M 54.61M 54.69M 54.93M 55.09M 55.09M
Normalized Net Operating Profit after Tax (NOPAT)
11 30 26 37 34 44 43 30 35 35 21
Normalized NOPAT Margin
3.86% 9.56% 8.29% 11.38% 10.74% 12.53% 11.93% 8.26% 9.64% 8.87% 5.31%
Pre Tax Income Margin
-11.60% 6.78% 13.97% 17.55% -99.62% 9.45% 9.48% 7.66% 7.59% 4.73% 11.90%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.17 2.39 3.80 4.58 -19.65 3.23 4.12 3.55 4.32 3.58 6.88
NOPAT to Interest Expense
0.27 1.96 1.66 2.32 2.23 2.96 3.93 4.39 4.21 40.56 2.63
EBIT Less CapEx to Interest Expense
0.02 1.61 2.66 3.92 -20.36 2.22 2.02 0.58 2.59 -0.82 3.01
NOPAT Less CapEx to Interest Expense
0.12 1.18 0.52 1.66 1.52 1.94 1.82 1.42 2.49 36.16 -1.24
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 9.39% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

LivaNova’s recent financial statements show a meaningful improvement in operating performance, although the latest quarter’s net income was heavily influenced by an unusually large income-tax benefit. The company has also reduced debt substantially from early 2025 levels, but cash has declined and working-capital demands remain elevated.

Revenue and profitability are trending higher. Second-quarter 2026 revenue reached $390.6 million, up 10.8% from $352.5 million in the restated second quarter of 2025 and 22.3% from $318.6 million in the second quarter of 2024. Gross profit increased to $273.7 million, producing a gross margin of approximately 70.1%, compared with 67.8% a year earlier. Operating income rose to $49.5 million, or roughly 12.7% of revenue, from $17.6 million, or 5.0% of revenue, in Q2 2025.

The improvement has been supported by better gross-margin performance and more moderate research and development spending. SG&A increased year over year, but R&D declined to $53.7 million from $58.7 million. Operating income also improved sequentially from $41.5 million in Q1 2026, despite higher SG&A and other operating expenses in the latest quarter.

Net income substantially exceeded operating profit, but the result requires caution. LivaNova reported $108.6 million of net income attributable to common shareholders, or $1.93 per diluted share, in Q2 2026. However, the company recorded a $90.2 million income-tax benefit. Without that benefit, reported earnings would have been considerably lower and more closely aligned with operating performance. Net income was $22.3 million in Q1 2026 and $27.2 million in the restated Q2 2025.

Cash generation improved, though working capital was a headwind. Operating cash flow increased to $66.6 million in Q2 2026 from $62.9 million in Q2 2025 and $15.2 million in Q1 2026. After $31.6 million of capital expenditures, estimated free cash flow was approximately $35.0 million. Still, changes in operating assets and liabilities consumed $67.7 million during the quarter, compared with a $2.0 million benefit in Q2 2025. Accounts receivable and inventory both increased from Q1 2026, tying up additional capital.

The balance sheet is healthier in several respects. Total debt fell to approximately $293.5 million at June 30, 2026, consisting of $3.6 million of short-term debt and $289.9 million of long-term debt. That compares with approximately $628.8 million at March 31, 2025 and $613.9 million at June 30, 2025. The reduction reflects substantial debt repayments over the past year and should lower interest costs; quarterly interest expense declined to $7.2 million from $14.9 million in Q2 2025.

However, cash and equivalents declined to $516.6 million from $738.4 million at the end of Q1 2025 and $593.6 million at the end of Q2 2025. Q2 2026 cash declined by $23.1 million, as operating cash flow was more than offset by capital spending, debt repayments and foreign-exchange effects. The company’s current ratio remained above 1.0 at approximately 1.45, but accrued expenses represented a significant portion of current liabilities.

  • Revenue growth is accelerating: Q2 2026 revenue increased 10.8% year over year and was more than 22% above Q2 2024.
  • Gross-margin expansion is significant: Gross margin improved to approximately 70.1% from 67.8% in Q2 2025 and 67.5% in Q2 2024.
  • Operating profitability improved: Operating income nearly tripled year over year to $49.5 million, while the operating margin expanded to approximately 12.7%.
  • Debt reduction is a major improvement: Total debt has fallen by more than $300 million from Q1 2025 levels, reducing interest expense and financial risk.
  • Operating cash flow remains positive: Q2 2026 operating cash flow of $66.6 million supported approximately $35.0 million of estimated free cash flow after capital expenditures.
  • Retained earnings improved: The retained-earnings deficit narrowed to $1.015 billion from $1.231 billion at the end of Q1 2025, helped by subsequent profitability.
  • Capital investment is increasing: Capital expenditures rose to $31.6 million in Q2 2026 from $15.1 million in Q2 2025, which could support growth but reduces near-term free cash flow.
  • Share count is relatively stable: Diluted weighted-average shares were 56.3 million in Q2 2026 versus 54.7 million in Q2 2025, creating modest dilution that investors should monitor.
  • Latest earnings were tax-driven: The $90.2 million income-tax benefit accounted for most of the quarter’s $108.6 million net income, making reported EPS an unreliable measure of recurring profitability.
  • Working capital remains a cash-flow risk: Operating assets and liabilities used $67.7 million of cash in Q2 2026, while goodwill and intangible assets totaled nearly $1.0 billion, creating exposure to future impairments or cash-conversion pressure.

Overall, the underlying trend is improving: LivaNova is growing revenue, expanding operating margins, generating positive free cash flow and carrying substantially less debt. Retail investors should nevertheless focus on recurring operating earnings and cash conversion rather than the headline Q2 2026 EPS, given the unusually large tax benefit and the quarter’s substantial working-capital outflow.

11/22/26 05:51 AM ETAI Generated. May Contain Errors.

LivaNova Financials - Frequently Asked Questions

According to the most recent income statement we have on file, LivaNova's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

LivaNova's net income appears to be on a downward trend, with a most recent value of -$242.47 million in 2025, compared with $57.85 million in 2014. The previous period was $63.23 million in 2024. See LivaNova's forecast for analyst expectations on what's next for the company.

LivaNova's total operating income in 2025 was $199.39 million, based on the following breakdown:
  • Total Gross Profit: $939.87 million
  • Total Operating Expenses: $740.48 million

Over the last 11 years, LivaNova's total revenue changed from $291.56 million in 2014 to $1.39 billion in 2025, a change of 376.1%.

In the past 13 quarters, LivaNova's cash and equivalents has ranged from $222.94 million in Q2 2023 to $738.44 million in Q1 2025, and is currently $563.47 million as of their latest financial filing in Q3 2026.

LivaNova had total debt of $426.69 million at the end of 2025, a 32.0% decrease from 2024, and none in 2014.

Over the last 11 years, LivaNova's book value per share changed from 10.48 in 2014 to 21.98 in 2025, a change of 109.7%.



Financial statements for NASDAQ:LIVN last updated on 11/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners